PMGC Holdings Inc. (ELAB), a diversified holding company, announced that it has utilised all of the $20 million commitment under its equity purchase facility with Streeterville Capital, LLC.
The facility was established under a securities purchase agreement in September, 2025, under which they agreed to issue and sell to the Investor shares of up to $20 million over time under the equity purchase facility (ELOC).
PMGC's acquisitions in the first quarter of 2026 include SVM Machining, Inc., in February 2026.
SVM Machining is a precision Computer Numerical Control (CNC) manufacturing company serving medical device and surgical robotics, aerospace, including satellite, spaceflight, and unmanned aerial vehicle (UAV) components, biotech and pharmaceutical lab automation, semiconductor wafer handling, and transportation customers.
Management believes such acquisitions strengthen PMGC's position in sectors where reliability, technical certification, and high switching costs support long-term customer retention and value creation.
Looking ahead, PMGC intends to pursue both organic growth and selective acquisitions, and its near-term priorities include advancing Northstrive Biosciences Inc.'s biopharmaceutical pipeline focused on muscle preservation and obesity, including EL-22's path toward a Phase 2 IND submission supported by the FDA.
ELAB has traded between $1.62 and $467.36 in the last year. The stock closed Tuesday's trade at $4.65, up 35.06%.
ELAB is currently up 33.48% at $4.60.
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.